Main > A1. CORP. INDEX. N-Nm > Needham & Co. LLC C2 > 2005. 08.29.2005. BioPharma.

---

"I think what you re seeing is a maturation of the industry," says Mark Monane, managing director of equity research at investment banking firm Needham & Co. Monane points to emerging technologies, such as antisense RNA medicines and targeted cancer vaccines, as an indication that the field has come of age.

He also points to an increased sophistication of biotech start-up companies as they prepare to bring their first products to market. This is true especially in partnerships with big drug companies. "Gone are the days when biotech companies partner in Phase I clinical trials for relatively low economics and loss of control," Monane says. "Partnership agreements now show the prowess of biotech companies in codevelopment and comarketing."




2005. 08.29.2005. BioPharma.'s products
This section has no products